Koichi Tabeta Selected Research

Koichi Tabeta Research Topics

Disease

28	Periodontitis 07/2022 - 05/2002
11	Infections 11/2020 - 03/2004
6	Inflammation (Inflammations) 01/2020 - 01/2011
5	Periodontal Diseases (Periodontal Disease) 02/2020 - 09/2008
4	Alveolar Bone Loss 01/2022 - 02/2019
3	Rheumatoid Arthritis 12/2021 - 11/2020
3	Virus Diseases (Viral Diseases) 06/2006 - 01/2003
2	Bone Resorption 03/2021 - 10/2019
2	Obesity 11/2020 - 12/2006
2	Hemorrhage 01/2019 - 06/2013
2	Atherosclerosis 01/2011 - 01/2010
1	Skin Diseases (Skin Disease) 07/2022
1	Hypersensitivity (Allergy) 07/2022
1	Pneumococcal Pneumonia 12/2021
1	Colitis 04/2021
1	Communicable Diseases (Infectious Diseases) 03/2021
1	Tooth Loss 01/2021
1	Non-alcoholic Fatty Liver Disease 01/2021
1	Dysbiosis 01/2021
1	Diabetes Complications 01/2021
1	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 01/2020
1	Acute Lung Injury 01/2020
1	Pneumonia (Pneumonitis) 01/2020
1	Kidney Diseases (Kidney Disease) 01/2019
1	Autolysis 01/2018
1	Lung Injury 01/2018
1	Pneumococcal Infections 01/2018
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2017
1	Periodontal Pocket (Periodontal Pockets) 01/2016

Drug/Important Bio-Agent (IBA)

7	CytokinesIBA 01/2022 - 05/2002
6	Proteins (Proteins, Gene)FDA Link 05/2022 - 10/2013
4	AntigensIBA 01/2019 - 12/2005
4	C-Reactive ProteinIBA 06/2012 - 01/2010
3	Biological ProductsIBA 12/2021 - 02/2019
3	Immunoglobulin G (IgG)IBA 08/2021 - 01/2020
3	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2019 - 03/2004
2	Leukocyte Elastase (Neutrophil Elastase)IBA 01/2022 - 03/2019
2	Streptococcus pneumoniae plY proteinIBA 12/2021 - 01/2018
2	Antirheumatic Agents (DMARD)IBA 12/2021 - 11/2020
2	Erythromycin (Erycette)FDA LinkGeneric 03/2021 - 01/2020
2	Silk FDA Link 04/2020 - 12/2019
2	Peptides (Polypeptides)IBA 10/2019 - 02/2019
2	InterleukinsIBA 10/2019 - 10/2011
2	Pharmaceutical PreparationsIBA 02/2019 - 01/2016
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 06/2013
2	Messenger RNA (mRNA)IBA 01/2017 - 10/2011
2	Ethylnitrosourea (N-Ethyl-N-nitrosourea)IBA 10/2013 - 12/2006
2	LDL CholesterolIBA 09/2012 - 01/2012
2	CholesterolIBA 09/2012 - 01/2011
2	LDL Lipoproteins (beta Lipoproteins)IBA 09/2012 - 01/2012
2	oxidized low density lipoproteinIBA 01/2012 - 01/2011
2	Interleukin-17 (Interleukin 17)IBA 10/2011 - 09/2008
2	Transcription Factors (Transcription Factor)IBA 01/2010 - 03/2009
1	MetalsIBA 07/2022
1	Cell Adhesion MoleculesIBA 01/2022
1	PolyphenolsIBA 12/2021
1	TeaIBA 12/2021
1	antiarrhythmic peptide (AAP)IBA 12/2021
1	cyclic citrullinated peptideIBA 08/2021
1	agalactosyl IGGIBA 08/2021
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 04/2021
1	Gingipain Cysteine EndopeptidasesIBA 04/2021
1	Drinking WaterIBA 04/2021
1	SolutionsIBA 04/2021
1	Dextrans (Dextran)FDA Link 04/2021
1	MacrolidesIBA 03/2021
1	EnzymesIBA 11/2020
1	Indicators and Reagents (Reagents)IBA 11/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2020
1	beta-thujaplicinIBA 04/2020
1	Tartrate-Resistant Acid PhosphataseIBA 04/2020
1	AntioxidantsIBA 02/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2020
1	Immunoglobulin E (IgE)IBA 01/2020
1	Penicillins (Penicillin)FDA Link 01/2020
1	AntibodiesIBA 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	Immunoglobulin A (IgA)IBA 01/2020
1	Josamycin (EN 141)IBA 01/2020
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 12/2019
1	LipopolysaccharidesIBA 10/2019
1	EndotoxinsIBA 10/2019
1	Bacterial AntigensIBA 10/2019
1	CreatinineIBA 01/2019
1	Nucleic AcidsIBA 01/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019
1	Lipocalin-2IBA 01/2019
1	Cadherins (E-Cadherin)IBA 01/2018
1	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2018
1	Glyceraldehyde-3-Phosphate Dehydrogenases (GAPD)IBA 01/2018
1	Toll-Like Receptor 4IBA 01/2018
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2018
1	Peptide Elongation Factor Tu (EF-Tu)IBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2016
1	sitafloxacinIBA 01/2016

Therapy/Procedure

7	Ligation 01/2022 - 02/2019
3	Oral Administration 04/2021 - 10/2019
3	Therapeutics 11/2020 - 06/2013
1	Glycemic Control 01/2021